Understanding the Therapeutic Impact of Disease-Modifying Therapies or No Treatment on Enlarging T1-Weighted Hypointense Lesions and Total T1-Weighted Hypointense Lesion Volume in MS
Current DMT classifications may have minimal influence on T1-weighted hypointense outcomes, highlighting the need for treatments that directly target ongoing tissue injury.
Authors
- T. Okuda Darin
- Tatum M. Moog (ORCID: https://orcid.org/0000-0002-1407-8621)
- Katy W. Burgess
- Morgan McCreary (ORCID: https://orcid.org/0000-0002-8378-460X)
- Tom G. Punnen
- Christine Lebrun-Frénay
Institutions
- Université Côte d'Azur (FR)
- Southwestern Medical Center (US)
- The University of Texas Southwestern Medical Center (US)
Publication Details
- Journal
- American Journal of Neuroradiology
- Published
- 2026-02-12
- DOI
- https://doi.org/10.3174/ajnr.a8994
- Primary Topic
- Multiple Sclerosis Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00